Schirwani Schaida, Novelli Antonio, Digilio Maria Cristina, Bourn David, Wilson Valerie, Roberts Catherine, Dallapiccola Bruno, Hobson Emma
Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Medical Genetics Unit, Medical Genetics Laboratory, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy.
Eur J Med Genet. 2019 Apr;62(4):243-247. doi: 10.1016/j.ejmg.2018.07.022. Epub 2018 Jul 23.
GPC3 and GPC4 are the only two genes in which mutations are known to cause Simpson-Golabi-Behmel syndrome type 1 (SGBS1). The majority of SGBS1 patients have point mutations or deletions in GPC3. Only one SGBS1 family has been reported with duplication of both GPC3 and GPC4. Although clinical presentation of SGBS1 in affected males is well defined, the phenotype in female carriers is less clear. In total, six female carriers with clinical expression of SGBS1 have been reported to date. In this study, we provide description of two families with rare duplications in both GPC3 and GPC4. These imbalances resulted in SGBS1 in males, while female carriers with skewed X-inactivation exhibited significant features of SGBS1 including congenital heart defect, hernias, intellectual disability and coarse facial features. In family 2, a SGBS diagnosis was not considered in the father until after the diagnosis had been first considered and made in the affected daughter. We emphasize on the importance of testing at risk females and careful examination of those who are found to be carriers of SGBS1. We also discuss and provide supportive evidence for the role of skewed X-inactivation in clinical expression of SGBS1 in female carriers.
GPC3和GPC4是已知突变会导致1型辛普森-戈拉比-贝梅尔综合征(SGBS1)的仅有的两个基因。大多数SGBS1患者在GPC3中有点突变或缺失。仅有一个SGBS1家系被报道同时存在GPC3和GPC4的重复。尽管SGBS1在受影响男性中的临床表现已明确,但女性携带者的表型尚不清楚。迄今为止,总共报道了6例有SGBS1临床表型的女性携带者。在本研究中,我们描述了两个家系,其GPC3和GPC4均存在罕见的重复。这些失衡在男性中导致了SGBS1,而X染色体失活偏向的女性携带者表现出SGBS1的显著特征,包括先天性心脏病、疝气、智力残疾和面部粗糙特征。在2号家系中,直到先对患病女儿进行诊断并确诊后,才考虑对父亲进行SGBS诊断。我们强调对有风险的女性进行检测以及对那些被发现是SGBS1携带者的人进行仔细检查的重要性。我们还讨论并提供了支持性证据,证明X染色体失活偏向在SGBS1女性携带者临床表型中的作用。